We have also demonstrated that RAP2A, the human homolog of Drosophila Rap2l, behaves as an ACD regulator in GBM neurosphere cultures, and its restitution to these GBM cultures, in which it is present at low levels, targets the stemness of GSCs, increasing the number of ACDs. The gene discussed is ACD; the disease is glioblastoma.